Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by Product Type
1.4.2 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
1.4.3 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by Deployment
1.4.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by End User
1.4.5 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by Application
1.4.6 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by Modality
1.4.7 LAMEA Vendor Neutral Archive (VNA) & PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug – 2024, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
5.1 LAMEA VNA Market by Country
5.2 LAMEA Vendor Neutral Archive (VNA) & PACS Market by VNA Type
5.2.1 LAMEA Multi-Department VNA Market by Country
5.2.2 LAMEA Department VNA Market by Country
5.2.3 LAMEA Multi-Site VNA Market by Country
5.3 LAMEA PACS Market by Country
5.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market by PACS Type
5.4.1 LAMEA Multi-Department PACS Market by Country
5.4.2 LAMEA Department PACS Market by Country
5.4.3 LAMEA Multi-Site PACS Market by Country
Chapter 6. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
6.1 LAMEA Independent Vendor Market by Country
6.2 LAMEA Third-party Vendor Market by Country
Chapter 7. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
7.1 LAMEA On-Premise Market by Country
7.2 LAMEA Cloud-Based Market by Country
7.3 LAMEA Hybrid Model Market by Country
Chapter 8. LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
8.1 LAMEA Hospitals & Clinics Market by Country
8.2 LAMEA Diagnostic Centers Market by Country
8.3 LAMEA Others Market by Country
Chapter 9. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
9.1 LAMEA Cardiology Market by Country
9.2 LAMEA Orthopedic Market by Country
9.3 LAMEA Oncology Market by Country
9.4 LAMEA Neurology Market by Country
9.5 LAMEA Obstetrics & Gynecology Market by Country
9.6 LAMEA Others Market by Country
Chapter 10. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality
10.1 LAMEA Computed Tomography Market by Country
10.2 LAMEA Mammography Market by Country
10.3 LAMEA MRI Market by Country
10.4 LAMEA Ultrasound Market by Country
10.5 LAMEA X-Rays Market by Country
10.6 LAMEA PET Market by Country
Chapter 11. LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country
11.1 Brazil Vendor Neutral Archive (VNA) & PACS Market
11.1.1 Brazil Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.1.1 Brazil Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.1.2 Brazil Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.2 Brazil Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.3 Brazil Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.4 Brazil Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.5 Brazil Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.6 Brazil Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2 Argentina Vendor Neutral Archive (VNA) & PACS Market
11.2.1 Argentina Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.1.1 Argentina Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.1.2 Argentina Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.2 Argentina Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.3 Argentina Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.4 Argentina Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.5 Argentina Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.6 Argentina Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3 UAE Vendor Neutral Archive (VNA) & PACS Market
11.3.1 UAE Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.1.1 UAE Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.1.2 UAE Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.2 UAE Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.3 UAE Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.4 UAE Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.5 UAE Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.6 UAE Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market
11.4.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.1.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.1.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.3 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.4 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.5 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.6 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Modality
11.5 South Africa Vendor Neutral Archive (VNA) & PACS Market
11.5.1 South Africa Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.5.1.1 South Africa Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.5.1.2 South Africa Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.5.2 South Africa Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.5.3 South Africa Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.5.4 South Africa Vendor Neutral Archive (VNA) & PACS Market by End User
11.5.5 South Africa Vendor Neutral Archive (VNA) & PACS Market by Application
11.5.6 South Africa Vendor Neutral Archive (VNA) & PACS Market by Modality
11.6 Nigeria Vendor Neutral Archive (VNA) & PACS Market
11.6.1 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.6.1.1 Nigeria Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.6.1.2 Nigeria Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.6.2 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.6.3 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.6.4 Nigeria Vendor Neutral Archive (VNA) & PACS Market by End User
11.6.5 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Application
11.6.6 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Modality
11.7 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market
11.7.1 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.7.1.1 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.7.1.2 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.7.2 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.7.3 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.7.4 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
11.7.5 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
11.7.6 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 12. Company Profiles
12.1 Hyland Software, Inc.
12.1.1 Company Overview
12.1.2 Recent strategies and developments:
12.1.2.1 Partnerships, Collaborations, and Agreements:
12.1.2.2 Product Launches and Product Expansions:
12.2 GE HealthCare Technologies, Inc.
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Segmental and Regional Analysis
12.2.4 Research & Development Expenses
12.2.5 Recent strategies and developments:
12.2.5.1 Partnerships, Collaborations, and Agreements:
12.2.6 SWOT Analysis
12.3 Koninklijke Philips N.V.
12.3.1 Company Overview
12.3.2 Financial Analysis
12.3.3 Segmental and Regional Analysis
12.3.4 Research & Development Expense
12.3.5 Recent strategies and developments:
12.3.5.1 Partnerships, Collaborations, and Agreements:
12.3.6 SWOT Analysis
12.4 Siemens Healthineers AG (Siemens AG)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.4.6 SWOT Analysis
12.5 Fujifilm Holdings Corporation
12.5.1 Company Overview
12.5.2 Financial Analysis
12.5.3 Segmental and Regional Analysis
12.5.4 Research & Development Expenses
12.5.5 Recent strategies and developments:
12.5.5.1 Product Launches and Product Expansions:
12.5.5.2 Acquisition and Mergers:
12.5.6 SWOT Analysis
12.6 IBM Corporation
12.6.1 Company Overview
12.6.2 Financial Analysis
12.6.3 Regional & Segmental Analysis
12.6.4 Research & Development Expenses
12.6.5 Recent strategies and developments:
12.6.5.1 Product Launches and Product Expansions:
12.6.6 SWOT Analysis
12.7 Carestream Health, Inc. (Onex Corporation)
12.7.1 Company Overview
12.7.2 SWOT Analysis
12.8 Novarad Enterprise Healthcare Solutions
12.8.1 Company Overview
12.8.2 Recent strategies and developments:
12.8.2.1 Partnerships, Collaborations, and Agreements:
12.8.2.2 Product Launches and Product Expansions:
12.8.3 SWOT Analysis
12.9 Canon, Inc. (Canon Medical Systems Corporation)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.9.5 Recent strategies and developments:
12.9.5.1 Partnerships, Collaborations, and Agreements:
12.9.5.2 Product Launches and Product Expansions:
12.9.6 SWOT Analysis
12.10. INFINITT Healthcare Co. Ltd.
12.10.1 Company Overview
12.10.2 Recent strategies and developments:
12.10.2.1 Partnerships, Collaborations, and Agreements:
12.10.2.2 Product Launches and Product Expansions:
12.10.3 SWOT Analysis
Unique Offerings 